Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on August 2, 2006
J Am Soc Nephrol 17: 2359-2362, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006060601
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006060601v1
17/9/2359    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marckmann, P.
Right arrow Articles by Thomsen, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marckmann, P.
Right arrow Articles by Thomsen, H. S.

Fast Track

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

Peter Marckmann*, Lone Skov{dagger}, Kristian Rossen{ddagger}, Anders Dupont§, Mette Brimnes Damholt*, James Goya Heaf* and Henrik S. Thomsen||

Departments of * Nephrology and || Diagnostic Radiology, Copenhagen University Hospital at Herlev, Herlev, Departments of {dagger} Dermatology and {ddagger} Pathology, Copenhagen University Hospital at Gentofte, Hellerup, and § Faculty of Health Sciences, Copenhagen University, Copenhagen, Denmark

Address correspondence to: Dr. Peter Marckmann, Department of Nephrology, Copenhagen University Hospital at Herlev, DK-2730 Herlev, Denmark. Phone: +45-44883634; Fax: +45-44884615; E-mail: peter.marckmann{at}dadlnet.dk

Nephrogenic systemic fibrosis is a new, rare disease of unknown cause that affects patients with renal failure. Single cases led to the suspicion of a causative role of gadodiamide that is used for magnetic resonance imaging. This study therefore reviewed all of the authors’ confirmed cases of nephrogenic systemic fibrosis (n = 13) with respect to clinical characteristics, gadodiamide exposure, and subsequent clinical course. It was found that all had been exposed to gadodiamide before the development of nephrogenic systemic fibrosis. The delay from exposure to first sign of the disease was 2 to 75 d (median 25 d). Odds ratio for acquiring the disease when gadodiamide exposed was 32.5 (95% confidence interval 1.9 to 549.2; P < 0.0001). Seven (54%) patients became severely disabled, and one died 21 mo after exposure. No other exposure/event than gadodiamide that was common to more than a minority of the patients could be identified. These findings indicate that gadodiamide plays a causative role in nephrogenic systemic fibrosis.




This article has been cited by other articles:


Home page
 CirculationHome page
M. R. Patel, P. J. Cawley, J. F. Heitner, I. Klem, M. A. Parker, W. A. Jaroudi, T. J. Meine, J. B. White, M. D. Elliott, H. W. Kim, et al.
Detection of Myocardial Damage in Patients With Sarcoidosis
Circulation, November 17, 2009; 120(20): 1969 - 1977.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
K. T. Tran, H. B. Prather, C. J. Cockerell, and H. Jacobe
UV-A1 Therapy for Nephrogenic Systemic Fibrosis
Arch Dermatol, October 1, 2009; 145(10): 1170 - 1174.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
W. A. High
Estimates of Risk, Empirical Treatment Observations, and Unexpected Laboratory Findings Reveal the Complexity of Nephrogenic Systemic Fibrosis
Arch Dermatol, October 1, 2009; 145(10): 1178 - 1182.
[Full Text] [PDF]

Home page
 RadiologyHome page
H. H. Abujudeh, R. Kaewlai, A. Kagan, L. B. Chibnik, R. M. Nazarian, W. A. High, and J. Kay
Nephrogenic Systemic Fibrosis after Gadopentetate Dimeglumine Exposure: Case Series of 36 Patients
Radiology, October 1, 2009; 253(1): 81 - 89.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
M. R. Prince, H. L. Zhang, J. C. Prowda, M. E. Grossman, and D. N. Silvers
Nephrogenic Systemic Fibrosis and Its Impact on Abdominal Imaging
RadioGraphics, October 1, 2009; 29(6): 1565 - 1574.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
B. M. Yeh, P. S. Liu, J. A. Soto, C. A. Corvera, and H. K. Hussain
MR Imaging and CT of the Biliary Tract
RadioGraphics, October 1, 2009; 29(6): 1669 - 1688.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. S. Lanzman, A. Voiculescu, C. Walther, A. Ringelstein, X. Bi, P. Schmitt, S.-M. Freitag, S. Won, A. Scherer, and D. Blondin
ECG-gated Nonenhanced 3D Steady-State Free Precession MR Angiography in Assessment of Transplant Renal Arteries: Comparison with DSA
Radiology, September 1, 2009; 252(3): 914 - 921.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
B. Taouli, R. L. Ehman, and S. B. Reeder
Advanced MRI Methods for Assessment of Chronic Liver Disease
Am. J. Roentgenol., July 1, 2009; 193(1): 14 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. F. Morris, Y. Zhang, H. Zhang, J. C. Prowda, D. N. Silvers, R. A. Fawwaz, and M. R. Prince
Features of Nephrogenic Systemic Fibrosis on Radiology Examinations
Am. J. Roentgenol., July 1, 2009; 193(1): 61 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
K. Shimada, H. Isoda, T. Okada, T. Kamae, S. Arizono, Y. Hirokawa, and K. Togashi
Unenhanced MR Portography With a Half-Fourier Fast Spin-Echo Sequence and Time-Space Labeling Inversion Pulses: Preliminary Results
Am. J. Roentgenol., July 1, 2009; 193(1): 106 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
M. D. Bridges, B. S. St. Amant, R. B. McNeil, J. G. Cernigliaro, J. P. Dwyer, and P. M. Fitzpatrick
High-Dose Gadodiamide for Catheter Angiography and CT in Patients With Varying Degrees of Renal Insufficiency: Prevalence of Subsequent Nephrogenic Systemic Fibrosis and Decline in Renal Function
Am. J. Roentgenol., June 1, 2009; 192(6): 1538 - 1543.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
K. Nael, M. Krishnam, S. G. Ruehm, H. J. Michaely, G. Laub, and J. P. Finn
Time-Resolved MR Angiography in the Evaluation of Central Thoracic Venous Occlusive Disease
Am. J. Roentgenol., June 1, 2009; 192(6): 1731 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
B. Ozgen, B. Oguz, and A. Dolgun
Diagnostic Accuracy of the Constructive Interference in Steady State Sequence Alone for Follow-Up Imaging of Vestibular Schwannomas
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 985 - 991.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
X. Liu, N. Berg, J. Sheehan, X. Bi, P. Weale, R. Jerecic, and J. Carr
Renal Transplant: Nonenhanced Renal MR Angiography with Magnetization-prepared Steady-State Free Precession
Radiology, May 1, 2009; 251(2): 535 - 542.
[Abstract] [Full Text] [PDF]

Home page
 Clin RiskHome page
G. Roditi
MRI contrast agent safety in renal impairment
Clin Risk, March 1, 2009; 15(2): 47 - 53.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
R. Agarwal, S. M. Brunelli, K. Williams, M. D. Mitchell, H. I. Feldman, and C. A. Umscheid
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis
Nephrol. Dial. Transplant., March 1, 2009; 24(3): 856 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
N. Bangsgaard, P. Marckmann, K. Rossen, and L. Skov
Nephrogenic Systemic Fibrosis: Late Skin Manifestations
Arch Dermatol, February 1, 2009; 145(2): 183 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
H S SU, R M NAZARIAN, and J A SCOTT
Appearance of nephrogenic fibrosing dermopathy on a bone scan
Br. J. Radiol., February 1, 2009; 82(974): e35 - e36.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. Perez-Rodriguez, S. Lai, B. D. Ehst, D. M. Fine, and D. A. Bluemke
Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment--Report of 33 Cases
Radiology, February 1, 2009; 250(2): 371 - 377.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. A. Perazella
Current Status of Gadolinium Toxicity in Patients with Kidney Disease
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 461 - 469.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
K. Juluru, J. Vogel-Claussen, K. J. Macura, I. R. Kamel, A. Steever, and D. A. Bluemke
Quality Initiatives MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient Safety1
RadioGraphics, January 1, 2009; 29(1): 9 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. D. Wiginton
Implications of NSF-Active and NSF-Inert in Nephrogenic Systemic Fibrosis
Am. J. Roentgenol., December 1, 2008; 191(6): 1864 - 1866.
[Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J Kay
Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction
Ann Rheum Dis, December 1, 2008; 67(Suppl_3): iii66 - iii69.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
K. Juluru, J. Vogel-Claussen, K. J. Macura, I. R. Kamel, A. Steever, and D. A. Bluemke
MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient Safety
RadioGraphics, November 19, 2008; (2008) 291085072.
[Abstract] [Full Text]

Home page
 RadiologyHome page
R. A. Halvorsen
Which Study When? Iodinated Contrast-enhanced CT Versus Gadolinium-enhanced MR Imaging
Radiology, October 1, 2008; 249(1): 9 - 15.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Marckmann, A. H. Nielsen, and J. J. Sloth
Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3280 - 3282.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
F. G. Shellock and A. Spinazzi
MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
Am. J. Roentgenol., October 1, 2008; 191(4): 1129 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. M. Colletti
Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm
Am. J. Roentgenol., October 1, 2008; 191(4): 1150 - 1153.
[Full Text] [PDF]

Home page
 Arch DermatolHome page
T. Liu, T. H. McCalmont, I. J. Frieden, M. L. Williams, M. K. Connolly, and A. E. Gilliam
The Stiff Skin Syndrome: Case Series, Differential Diagnosis of the Stiff Skin Phenotype, and Review of the Literature
Arch Dermatol, October 1, 2008; 144(10): 1351 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Steen, C. Merten, S. Refle, R. Klingenberg, T. Dengler, E. Giannitsis, and H. A. Katus
Prevalence of Different Gadolinium Enhancement Patterns in Patients After Heart Transplantation
J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1160 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. R. Prince, H. Zhang, M. Morris, J. L. MacGregor, M. E. Grossman, J. Silberzweig, R. L. DeLapaz, H. J. Lee, C. M. Magro, and A. M. Valeri
Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers
Radiology, September 1, 2008; 248(3): 807 - 816.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. G. Lansberg, V. N. Thijs, R. Bammer, J.-M. Olivot, M. P. Marks, L. R. Wechsler, S. Kemp, and G. W. Albers
The MRA-DWI Mismatch Identifies Patients With Stroke Who Are Likely to Benefit From Reperfusion
Stroke, September 1, 2008; 39(9): 2491 - 2496.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
M E ABOU EL-GHAR, A A SHOKEIR, H F REFAIE, and T A EL-DIASTY
MRI in patients with chronic obstructive uropathy and compromised renal function: a sole method for morphological and functional assessment
Br. J. Radiol., August 1, 2008; 81(968): 624 - 629.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
N. M. Rofsky
Nephrogenic systemic fibrosis: considerations for the cardiologist.
J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 457 - 459.
[Full Text] [PDF]

Home page
 CJASNHome page
J. A. Schroeder, C. Weingart, B. Coras, I. Hausser, S. Reinhold, M. Mack, V. Seybold, T. Vogt, B. Banas, F. Hofstaedter, et al.
Ultrastructural Evidence of Dermal Gadolinium Deposits in a Patient with Nephrogenic Systemic Fibrosis and End-Stage Renal Disease
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 968 - 975.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
N. M. Rofsky, A. D. Sherry, and R. E. Lenkinski
Nephrogenic Systemic Fibrosis: A Chemical Perspective
Radiology, June 1, 2008; 247(3): 608 - 612.
[Full Text] [PDF]

Home page
 RadiologyHome page
Y. Tsushima, A. Takahashi-Taketomi, and K. Endo
Nephrogenic Systemic Fibrosis in Japan: Advisability of Keeping the Administered Dose as Low as Possible
Radiology, June 1, 2008; 247(3): 915 - 916.
[Full Text] [PDF]

Home page
 CJASNHome page
R. F. Reilly
Risk for Nephrogenic Systemic Fibrosis with Gadoteridol (ProHance) in Patients Who Are on Long-Term Hemodialysis
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 747 - 751.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. A. Perazella
How Should Nephrologists Approach Gadolinium-based Contrast Imaging in Patients with Kidney Disease?
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 649 - 651.
[Full Text] [PDF]

Home page
 RadiologyHome page
C. Y. Kim, R. A. Mirza, J. A. Bryant, E. D. Whiting, D. M. Delong, C. E. Spritzer, and E. M. Merkle
Central Veins of the Chest: Evaluation with Time-resolved MR Angiography
Radiology, May 1, 2008; 247(2): 558 - 566.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. D. Wiginton, B. Kelly, A. Oto, M. Jesse, P. Aristimuno, R. Ernst, and G. Chaljub
Gadolinium-Based Contrast Exposure, Nephrogenic Systemic Fibrosis, and Gadolinium Detection in Tissue
Am. J. Roentgenol., April 1, 2008; 190(4): 1060 - 1068.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
L. P. Golding and J. M. Provenzale
Nephrogenic Systemic Fibrosis: Possible Association with a Predisposing Infection
Am. J. Roentgenol., April 1, 2008; 190(4): 1069 - 1075.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. C. Textor, J. F. Glockner, L. O. Lerman, S. Misra, M. A. McKusick, S. J. Riederer, J. P. Grande, S. I. Gomez, and J. C. Romero
The Use of Magnetic Resonance to Evaluate Tissue Oxygenation in Renal Artery Stenosis
J. Am. Soc. Nephrol., April 1, 2008; 19(4): 780 - 788.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
W. M. Shabana, R. H. Cohan, J. H. Ellis, H. K. Hussain, I. R. Francis, L. D. Su, S. K. Mukherji, and R. D. Swartz
Nephrogenic Systemic Fibrosis: A Report of 29 Cases
Am. J. Roentgenol., March 1, 2008; 190(3): 736 - 741.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Kay, H. Bazari, L. L. Avery, and A. F. Koreishi
Case 6-2008 -- A 46-Year-Old Woman with Renal Failure and Stiffness of the Joints and Skin
N. Engl. J. Med., February 21, 2008; 358(8): 827 - 838.
[Full Text] [PDF]

Home page
 Cleveland Clinic Journal of MedicineHome page
N. ISSA, E. D. POGGIO, R. A. FATICA, R. PATEL, P. M. RUGGIERI, and R. J. HEYKA
Nephrogenic systemic fibrosis and its association with gadolinium exposure during MRI
Cleveland Clinic Journal of Medicine, February 1, 2008; 75(2): 95 - 111.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
T. Dickfeld, P. Lei, V. Dilsizian, J. Jeudy, J. Dong, A. Voudouris, R. Peters, M. Saba, R. Shekhar, and S. Shorofsky
Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography.
J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 73 - 82.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. U. Herborn, V. M. Runge, D. M. Watkins, J. M. Gendron, and L. G. Naul
MR Angiography of the Renal Arteries: Intraindividual Comparison of Double-Dose Contrast Enhancement at 1.5 T with Standard Dose at 3 T
Am. J. Roentgenol., January 1, 2008; 190(1): 173 - 177.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
J. R. Leyendecker, C. E. Barnes, and R. J. Zagoria
MR Urography: Techniques and Clinical Applications
RadioGraphics, January 1, 2008; 28(1): 23 - 46.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. R. Dillman, J. H. Ellis, R. H. Cohan, P. J. Strouse, and S. C. Jan
Frequency and Severity of Acute Allergic-Like Reactions to Gadolinium-Containing IV Contrast Media in Children and Adults
Am. J. Roentgenol., December 1, 2007; 189(6): 1533 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
A. Kahana, M. J. Lucarelli, A. M. Grayev, J. J. Van Buren, C. N. Burkat, and L. R. Gentry
Noninvasive Dynamic Magnetic Resonance Angiography With Time-Resolved Imaging of Contrast KineticS (TRICKS) in the Evaluation of Orbital Vascular Lesions
Arch Ophthalmol, December 1, 2007; 125(12): 1635 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Marckmann, L. Skov, K. Rossen, J. G. Heaf, and H. S. Thomsen
Case-control study of gadodiamide-related nephrogenic systemic fibrosis
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3174 - 3178.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. L. Nortier and V. del Marmol
Nephrogenic systemic fibrosis the need for a multidisciplinary approach
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3097 - 3101.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. B. Othersen, J. C. Maize Jr., R. F. Woolson, and M. N. Budisavljevic
Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3179 - 3185.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. Remy-Jardin, M. Pistolesi, L. R. Goodman, W. B. Gefter, A. Gottschalk, J. R. Mayo, and H. D. Sostman
Management of Suspected Acute Pulmonary Embolism in the Era of CT Angiography: A Statement from the Fleischner Society
Radiology, November 1, 2007; 245(2): 315 - 329.
[Full Text] [PDF]

Home page
 J Electron Microsc (Tokyo)Home page
C. Thakral and J. L. Abraham
Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of Gadolinium deposits in skin
J. Electron Microsc. (Tokyo), October 19, 2007; (2007) dfm020v1.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
T. A. Collidge, P. C. Thomson, P. B. Mark, J. P. Traynor, A. G. Jardine, S. T. W. Morris, K. Simpson, and G. H. Roditi
Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort
Radiology, October 1, 2007; 245(1): 168 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Swaminathan and S. V. Shah
New Insights into Nephrogenic Systemic Fibrosis
J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2636 - 2643.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol., September 4, 2007; 50(10): 988 - 1003.
[Full Text] [PDF]

Home page
 RadiologyHome page
G. Saab, A. Abu-Alfa, E. A. Sadowski, and A. Djamali
Are Patients with Moderate Renal Failure at Risk for Developing Nephrogenic Systemic Fibrosis?
Radiology, September 1, 2007; 244(3): 930 - 932.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. S Peak and A. Sheller
Risk Factors for Developing Gadolinium-Induced Nephrogenic Systemic Fibrosis
Ann. Pharmacother., September 1, 2007; 41(9): 1481 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
H. Richmond, J. Zwerner, Y. Kim, and D. Fiorentino
Nephrogenic Systemic Fibrosis: Relationship to Gadolinium and Response to Photopheresis
Arch Dermatol, August 1, 2007; 143(8): 1025 - 1030.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. B. Mark, R. K. Patel, and A. G. Jardine
Are we overestimating left ventricular abnormalities in end-stage renal disease?
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1815 - 1819.
[Full Text] [PDF]

Home page
 CJASNHome page
S. S. DeLoach and E. R. Mohler III
Peripheral Arterial Disease: A Guide for Nephrologists
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 839 - 846.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
E. Kanal, A. J. Barkovich, C. Bell, J. P. Borgstede, W. G. Bradley Jr., J. W. Froelich, T. Gilk, J. R. Gimbel, J. Gosbee, E. Kuhni-Kaminski, et al.
ACR Guidance Document for Safe MR Practices: 2007
Am. J. Roentgenol., June 1, 2007; 188(6): 1447 - 1474.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
H. S. Thomsen and S. K. Morcos
Nephrogenic Systemic Fibrosis and Nonionic Linear Chelates
Am. J. Roentgenol., June 1, 2007; 188(6): W580 - W580.
[Full Text] [PDF]

Home page
 CJASNHome page
J. L. Holley
Screening, Diagnosis, and Treatment of Cancer in Long-Term Dialysis Patients
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 604 - 610.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
Nephrogenic Fibrosing Dermopathy Associated With Exposure to Gadolinium-Containing Contrast Agents--St. Louis, Missouri, 2002-2006
JAMA, April 11, 2007; 297(14): 1542 - 1544.
[Full Text] [PDF]

Home page
 RadiologyHome page
E. A. Sadowski, L. K. Bennett, M. R. Chan, A. L. Wentland, A. L. Garrett, R. W. Garrett, and A. Djamali
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Radiology, April 1, 2007; 243(1): 148 - 157.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
M. A. Perazella
Nephrogenic Systemic Fibrosis, Kidney Disease, and Gadolinium: Is There a Link?
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 200 - 202.
[Full Text] [PDF]

Home page
 CJASNHome page
P. Yerram, G. Saab, P. R. Karuparthi, M. R. Hayden, and R. Khanna
Nephrogenic Systemic Fibrosis: A Mysterious Disease in Patients with Renal Failure--Role of Gadolinium-Based Contrast Media in Causation and the Beneficial Effect of Intravenous Sodium Thiosulfate
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 258 - 263.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
A. Deo, M. Fogel, and S. E. Cowper
Nephrogenic Systemic Fibrosis: A Population Study Examining the Relationship of Disease Development to Gadolinium Exposure
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 264 - 267.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
D. R. Broome, M. S. Girguis, P. W. Baron, A. C. Cottrell, I. Kjellin, and G. A. Kirk
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Am. J. Roentgenol., February 1, 2007; 188(2): 586 - 592.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Grobner
Reply
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3604 - 3605.
[Full Text] [PDF]

Home page
 PERSPECT VASC SURG ENDOVASC THERHome page
C. E. Spritzer
Progress in MR Imaging of the Venous System
Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2002; 21(2): 105 - 116.
[Abstract] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673